MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
Teladoc Health Accounts Receivables 2011-2026 | TDOC
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Teladoc Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 214 M | 217 M | 211 M | 169 M | 169 M | 56.9 M | 43.6 M | 27.1 M | 13.8 M | 12.1 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 217 M | 12.1 M | 113 M |
Quarterly Accounts Receivables Teladoc Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 225 M | 233 M | 214 M | 212 M | 218 M | 214 M | 217 M | 206 M | 215 M | 216 M | 211 M | 202 M | - | 192 M | 169 M | 178 M | 179 M | 178 M | 169 M | 169 M | 169 M | 169 M | 56.9 M | 56.9 M | 56.9 M | 56.9 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 6.84 M | 6.84 M | 6.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 233 M | 6.84 M | 109 M |
Accounts Receivables of other stocks in the Health information services industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
1.16 B | - | - | $ 27.9 B |  USA |
 |
Change Healthcare
CHNG
|
733 M | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
59.7 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
480 M | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
9.11 M | - | 0.29 % | $ 206 M | USA |
 |
Evolent Health
EVH
|
269 M | $ 4.18 | 0.84 % | $ 392 M | USA |
 |
Health Catalyst
HCAT
|
57.2 M | $ 2.46 | -1.8 % | $ 148 M | USA |
 |
HealthStream
HSTM
|
30.2 M | $ 22.42 | -1.45 % | $ 681 M | USA |
 |
iCAD
ICAD
|
7.21 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
486 K | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
105 M | $ 98.07 | 0.31 % | $ 8.39 B | USA |
 |
American Well Corporation
AMWL
|
71.9 M | $ 5.23 | 0.77 % | $ 78.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
327 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
12.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
So-Young International
SY
|
52.9 M | $ 2.61 | 1.76 % | $ 207 M |  China |
 |
GoodRx Holdings
GDRX
|
146 M | $ 2.78 | -2.63 % | $ 1.07 B | USA |
 |
OptimizeRx Corporation
OPRX
|
36.3 M | $ 13.25 | -4.33 % | $ 227 M | USA |
 |
Omnicell
OMCL
|
256 M | $ 50.47 | 6.35 % | $ 2.32 B | USA |
 |
1Life Healthcare
ONEM
|
103 M | - | - | $ 3.37 B | USA |
 |
Progyny
PGNY
|
235 M | $ 27.54 | 2.76 % | $ 2.36 B | USA |
 |
Phreesia
PHR
|
64.9 M | $ 16.91 | -3.54 % | $ 923 M | USA |
 |
Premier
PINC
|
99.1 M | $ 28.26 | - | $ 2.33 B | USA |
 |
Zhongchao
ZCMD
|
10.3 M | $ 0.53 | 1.56 % | $ 2.76 M | China |
 |
R1 RCM
RCM
|
131 M | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
5.95 M | - | -46.64 % | $ 10.4 M | USA |
 |
Schrödinger
SDGR
|
236 M | $ 18.67 | -0.52 % | $ 1.36 B | USA |
 |
NextGen Healthcare
NXGN
|
77.5 M | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
156 M | - | -0.02 % | $ 7.21 B | USA |
 |
10x Genomics
TXG
|
115 M | $ 19.32 | -3.35 % | $ 2.26 B | USA |
 |
Streamline Health Solutions
STRM
|
1.58 M | - | - | $ 21.4 M | USA |
 |
Veeva Systems
VEEV
|
852 M | $ 242.72 | 1.46 % | $ 39 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
19.3 M | - | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
373 K | $ 0.2 | -1.51 % | $ 292 K | USA |